New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Kiniksa Pharmaceuticals, Ltd.
KNSA
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

2B

Biotechnology

Next Earning date - 29 Oct 2024

2B

Biotechnology

Next Earning date - 29 Oct 2024

27.59USD
Shape0.15 ( 0.55%)
favorite-chart

Relative Strenght

61
favorite-chart

Volume Buzz

-12%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

2%

Quote Panel

Shape
Updated October 29, 2024
1W 2.79 % 1M 10.40 % 3M 4.19 % 1Y 75.96 %

Key Metrics

Shape
  • Market Cap

    1.97B


  • Shares Outstanding

    71.24M


  • Share in Float

    67.98M


  • Dividende

    0


  • Earning Date

    29 Oct 2024


  • Price Target

    27.59


  • Average Volume

    368204


  • Beta

    0.32


  • Range

    14.12-28.15


  • Industry

    Biotechnology


  • Website

    https://www.kiniksa.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

5.80x

P/S Ratio

4.50x

P/B Ratio

0.0

Debt/Equity

-3.0%

Net Margin

$-0.1

EPS

How KNSA compares to sector?

P/E Ratio

Relative Strength

Shape

KNSA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$574M

Shape428%

2025-Revenue

$0.61

Shape1201%

2025-EPS

$110M

Shape35048%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Jefferies

initialise

Previous: Not converted

2024-09-13

Now: Buy

Wells Fargo

initialise

Previous: Not converted

2024-05-03

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+252%

0.67
vs -0.44

Q4.22

arrow
arrow

+111%

0.06
vs -0.53

Q1.23

arrow
arrow

N/A

-0.18
vs -0.36

Q2.23

arrow
arrow

N/A

-0.02
vs -0.29

Q3.23

arrow
arrow

N/A

-0.20
vs 0.67

Q4.23

arrow
arrow

-33%

0.04
vs 0.06

Q1.24

arrow
arrow

N/A

-0.25
vs -0.18

Q2.24

arrow
arrow

N/A

-0.06
vs -0.02

Q3.24

arrow
arrow

+112%

0.02
vs -0.20

Q4.24

arrow
arrow

+46%

0.06
vs 0.04

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+720%

99.1M  vs 12.1M

Q4.22

arrow
arrow

+230%

61.9M  vs 18.7M

Q1.23

arrow
arrow

+50%

48.3M  vs 32.2M

Q2.23

arrow
arrow

+165%

71.5M  vs 27M

Q3.23

arrow
arrow

-32%

67M  vs 99.1M

Q4.23

arrow
arrow

+35%

83.4M  vs 61.9M

Q1.24

arrow
arrow

+65%

79.9M  vs 48.3M

Q2.24

arrow
arrow

+52%

108.6M  vs 71.5M

Q3.24

arrow
arrow

+66%

111.5M  vs 67M

Q4.24

arrow
arrow

+47%

122.4M  vs 83.4M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-45%

-0.45
vs 0.03

Q4.22

arrow
arrow

-1%

-0.01
vs -0.45

Q1.23

arrow
arrow

+2%

0.02
vs -0.01

Q2.23

arrow
arrow

-3%

-0.03
vs 0.02

Q3.23

arrow
arrow

+3%

0.03
vs -0.03

Q4.23

arrow
arrow

+6%

0.06
vs 0.03

Q1.24

arrow
arrow

-4%

-0.04
vs 0.06

Q2.24

arrow
arrow

-1%

-0.01
vs -0.04

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

115

115
vs 97

19%

Q4.22

arrow
arrow

135

135
vs 115

17%

Q1.23

arrow
arrow

139

139
vs 135

3%

Q2.23

arrow
arrow

136

136
vs 139

-2%

Q3.23

arrow
arrow

145

145
vs 136

7%

Q4.23

arrow
arrow

150

150
vs 145

3%

Q1.24

arrow
arrow

160

160
vs 150

7%

Q2.24

arrow
arrow

5

5
vs 160

-97%

Earnings Growth

Latest News